CIK 0001356090 · Non-accelerated filer<br>Smaller reporting company
PRECIGEN, INC.
Sign in to watch- Ticker
- PGEN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- Phone
- 301-556-9900
- Business address
- 20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD, 20876
- Former names
- INTREXON CORP
- Open-market buys, last 90 days
- $24,662
- in 1 filing
- Open-market sales, last 90 days
- $2,345,145
- in 3 filings, $969K under 10b5-1 plans
Net −$2,320,483. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-23 | Lehr Donald P. Chief Legal Officer | Option exercise | +62,500 | 784,592 | ||
| 2026-05-23 | Lehr Donald P. Chief Legal Officer | Option exercise · Restricted Stock Units | −62,500 | 62,500 | ||
| 2026-04-20 | Lehr Donald P. Chief Legal Officer | Grant or award · Option to Purchase Common Stock (Right to Buy) | +358,000 | 358,000 | ||
| 2026-04-20 | Lehr Donald P. Chief Legal Officer | Grant or award · Restricted Stock Units | +107,000 | 107,000 | ||
| 2026-04-20 | Sabzevari Helen President and CEO | Grant or award · Option to Purchase Common Stock (Right to Buy) | +1,366,000 | 1,366,000 | ||
| 2026-04-20 | Sabzevari Helen President and CEO | Grant or award · Restricted Stock Units | +410,000 | 410,000 | ||
| 2026-04-20 | Shah Rutul R Chief Operating Officer | Grant or award · Option to Purchase Common Stock (Right to Buy) | +395,000 | 395,000 | ||
| 2026-04-20 | Shah Rutul R Chief Operating Officer | Grant or award · Restricted Stock Units | +118,000 | 118,000 | ||
| 2026-04-20 | Tennant Phil Chief Commercial Officer | Grant or award · Option to Purchase Common Stock (Right to Buy) | +385,000 | 385,000 | ||
| 2026-04-20 | Tennant Phil Chief Commercial Officer | Grant or award · Restricted Stock Units | +115,000 | 115,000 | ||
| 2026-04-20 | Thomasian Harry Jr. Chief Financial Officer | Grant or award · Option to Purchase Common Stock (Right to Buy) | +399,000 | 399,000 | ||
| 2026-04-20 | Thomasian Harry Jr. Chief Financial Officer | Grant or award · Restricted Stock Units | +120,000 | 120,000 | ||
| 2026-03-30 | KIRK RANDAL J Director | Sale | −1,108,998 | $3.30 | $3.7M | 80,672,818 |
| 2026-03-30 | KIRK RANDAL J Director | Sale | −50,797 | $3.30 | $168K | 426,695 |
| 2026-03-30 | KIRK RANDAL J Director | Sale | −370,847 | $3.30 | $1.2M | 3,238,210 |
| 2026-03-30 | KIRK RANDAL J Director | Sale | −152,063 | $3.30 | $502K | 1,463,571 |
| 2026-03-30 | KIRK RANDAL J Director | Sale | −50,797 | $3.30 | $168K | 425,732 |
| 2026-03-30 | KIRK RANDAL J Director | Sale | −426,199 | $3.30 | $1.4M | 3,358,917 |
| 2026-03-30 | KIRK RANDAL J Director | Sale | −168,794 | $3.30 | $557K | 1,425,544 |
| 2026-03-30 | KIRK RANDAL J Director | Sale | −47,101 | $3.30 | $155K | 519,061 |
Page 4 of 26 · 502 trades